These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Impact of an immune modulator fingolimod on acute ischemic stroke. Fu Y; Zhang N; Ren L; Yan Y; Sun N; Li YJ; Han W; Xue R; Liu Q; Hao J; Yu C; Shi FD Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18315-20. PubMed ID: 25489101 [TBL] [Abstract][Full Text] [Related]
16. FTY720: a most promising immunosuppressant modulating immune cell functions. Zhang Z; Schluesener HJ Mini Rev Med Chem; 2007 Aug; 7(8):845-50. PubMed ID: 17692046 [TBL] [Abstract][Full Text] [Related]
17. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. Morris MA; McDuffie M; Nadler JL; Ley K Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767 [TBL] [Abstract][Full Text] [Related]
18. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Rolland WB; Manaenko A; Lekic T; Hasegawa Y; Ostrowski R; Tang J; Zhang JH Acta Neurochir Suppl; 2011; 111():213-7. PubMed ID: 21725758 [TBL] [Abstract][Full Text] [Related]
19. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection. Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927 [TBL] [Abstract][Full Text] [Related]
20. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]